Predicting myocardial infarction and other serious cardiac outcomes using high-sensitivity cardiac troponin T in a high-risk stable population

Clinical Biochemistry

Volumn 46, Issue 1-2, 2013, Pages 5-9

  McQueen, Matthew J ^a   Kavsak, Peter A ^a   Xu, Liqin ^a   Shestakovska, Olga ^a   Yusuf, Salim ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Cardiovascular death; Heart failure; High sensitivity cardiac troponin T; Myocardial infarction; Risk stratification; Stable cardiovascular disease

Indexed keywords

HIGH SENSITIVITY TROPONIN T; TROPONIN T; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE;

AGED; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; ROC CURVE; STROKE; TROPONIN T;

EID: 84871750501     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.10.003     Document Type: Article

References (32)

1. Latini R., Masson S., Anand I.S., Missov E., Carlson M., Vago T., et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007, 116:1242-1249.
2. Venge P., Johnston N., Lindahl B., James S. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I Access prototype assay and the impact on the diagnosis of myocardial ischemia. J Am Coll Cardiol 2009, 54:1165-1172.
3. Kavsak P.A., Wang X., Ko D.T., MacRae A.R., Jaffe A.S. Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population. Clin Chem 2009, 55:1809-1815.
4. Omland T., de Lemos J.A., Sabatine M.S., Christophi C.A., Rice M.M., Jablonski K.A., et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009, 361:2538-2547.
5. Kavsak P.A., Xu L., Yusuf S., McQueen M.J. High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population. Clin Chem 2011, 57:1146-1153.
6. Reichlin T., Hochholzer W., Bassetti S., Steuer S., Steizig C., Hartwiger S., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009, 361:858-867.
7. Giannitsis E., Becker M., Kurz K., Hess G., Zdunek D., Katus H.A. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin Chem 2010, 56:642-650.
8. Januzzi J.L., Bamberg F., Lee H., Truong Q.A., Nichols J.H., Karakas M., et al. High-sensitivity troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomography. Circulation 2010, 121:1227-1234.
9. deFilippi C.R., de Lemos J.A., Christenson R.H., Gottdiener J.S., Kop W.J., Zhan M., et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010, 304:2494-2502.
10. de Lemos J.A., Drazner M.H., Omland T., Ayers C.R., Khera A., Rohatgi A., et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010, 304:2503-2512.
11. Reiter M., Twerenbold R., Reichlin T., Benz B., Haaf P., Meissner J., et al. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J 2011, 32:1379-1389.
12. Reichlin T., Irfan A., Twerenbold R., Reiter M., Hochholzer W., Burkhalter H., et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 2011, 124:136-145.
13. Saunders J.T., Nambi V., de Lemos J.A., Chambless L.E., Virani S.S., Boerwinkle E., et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the atherosclerosis risk in communities study. Circulation 2011, 123:1367-1376.
14. Everett B.M., Cook N.R., Magnone M.C., Bobadilla M., Kim E., Rifai N., et al. Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study. Circulation 2011, 123:2811-2818.
15. Hochholzer W., Reichlin T., Twerenbold R., Stelzig C., Hochholzer K., Meissner J., et al. Incremental value of high-sensitivity cardiac troponin T for risk prediction in patients with suspected acute myocardial infarction. Clin Chem 2011, 57:1319-1326.
16. Apple F.S., Jaffe A.S. Clinical Implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: user beware. Clin Chem 2012, 58:1598.
17. Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., Dagenais G. Effects of angiotension-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000, 342:145-153.
18. Blankenberg S., McQueen M.J., Smieja M., Pogue J., Balion C., Lonn E., et al. Comparative impact on multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the heart outcomes prevention evaluation (HOPE) study. Circulation 2006, 114:201-208.
19. Arnold J.M., Yusuf S., Young J., Mathew J., Johnstone D., Avezum A., et al. Prevention of heart failure in patients in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 2003, 107:1284-1290.
20. Giannitsis E., Kurz K., Hallermayer K., Jarausch J., Jaffe A.S., Katus H.A. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010, 56:254-261.
21. Saenger A.K., Beyrau R., Braun S., Cooray R., Dolci A., Freidank H., et al. Multicentre analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta 2011, 412:748-754.
22. Collinson P.O., Heung Y.M., Gaze D., Boa F., Senior R., Christenson R., et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem 2012, 58:219-225.
23. Kavsak P.A., Hill S.A., Bhanich Supapol W., Devereaux P.J., Worster A. Biomarkers for predicting serious cardiac outcomes at 72 hours in patients presenting early after chest pain onset with symptoms of acute coronary syndromes. Clin Chem 2012, 58:298-302.
24. Harrell F.E., Lee K.L., Mark D.B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996, 15:361-387.
25. Pencina M.J., D'Agostino R.B., Steyerberg E.W. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011, 30:11-21.
26. Pencina M.J., D'Agostino R.B., D'Agostino R.B., Vasan R.S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008, 27:157-172.
27. Zethelius B., Berglund L., Sundström J., Ingelsson E., Basu S., Larsson A., et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008, 358:2107-2116.
28. Möckel M., Searle J., Hartmann O., Anker S.D., Peacock W.F., Wu A.H., et al. Mid-regional pro-adrenomedullin improves disposition strategies for patients with acute dyspnoea: results from the BACH trial. Emerg Med J Sep 9 2012, [Epub ahead of print].
29. Turer A.T., Addo T.A., Martin J.L., Sabatine M.S., Lewis G.D., Gerszten R.E., et al. Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay. J Am Coll Cardiol 2011, 57:2398-2405.
30. Lindahl B., Venge P., James S. The new high-sensitivity cardiac troponin T assay improves risk assessment in acute coronary syndromes. Am Heart J 2010, 160:224-229.
31. Kavsak P.A., Newman A.M., Ko D.T., Palomaki G.E., Lustig V., MacRae A.R., et al. Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms?. Clin Chem 2008, 54:747-751.
32. Mansour M., Clark L., Kavsak P.A. Effect of freeze-thaw and refrigeration conditions on high-sensitivity troponin T concentrations. Ann Clin Biochem 2012, 49:101-102.